Insurance details matter
Mongioi L, Calogero AE, Vicari E, Condorelli RA, Russo GI, Privitera S, et al
The retatrutide versus semaglutide comparison and the head-to-head data with tirzepatide both favor retatrutide for raw weight loss
Telehealth providers owned by Australian online healthcare company Eucalyptus have begun prescribing semaglutide (sold as Ozempic) for weight loss, seemingly in contravention of a Therapeutic Goods Administration (TGA) request to avoid off-label use of the popular drug
Patients who received fewer than 12 orders achieved a significantly lower weight loss percentage than those who received 12 or more orders
In addition, recent advances in computational analysis and model building also support the identification of specific, high-affinity PPI drug hits